华特达因:子公司签署褪黑素颗粒(曼乐静)总经销合同
Group 1 - The company Huate Dain announced that its subsidiary Beijing Dain Kangjian has reached an agreement with Japan's Nobel Pharma Co., Ltd. for the exclusive general distribution of melatonin granules (Manlejing®) in mainland China [1] - Dain Kangjian will be the exclusive general distributor of this product in mainland China, excluding Hong Kong, Macau, and Taiwan [1] - The product is expected to be approved for sale in China by July 2025 and is the first melatonin formulation approved for treating sleep difficulties in children aged 6-15 with neurodevelopmental disorders in the country [1]